Aclarion Inc. (ACONW)
NasdaqCM: ACONW
· Real-Time Price · USD
0.03
+0.00 (0.00%)
At close: Aug 27, 2026, 2:47 PM
The price, the headline numbers and the latest news, in one place.
Aclarion Inc. (ACONW) Stock Price, Analysis & Data
0.00% (1D)
| Bid | n/a |
| Market Cap | n/a |
| Revenue (ttm) | 83.77K |
| Net Income (ttm) | -9.2M |
| 1.22 | |
| -6.58 | |
| n/a | |
| n/a | |
| P/B (ttm) | n/a |
| P/S (ttm) | n/a |
| Earnings Date | n/a |
| Ask | n/a |
| Volume | 13,777 |
| Avg. Volume (20D) | |
| Open | 0.05 |
| Previous Close | 0.03 |
| Day's Range | 0.03 - 0.03 |
| 52-Week Range | 0.03 - 0.03 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About ACONW
Aclarion, Inc. operates as a healthcare technology company in the United States. It uses magnetic resonance spectroscopy (MRS) combined with proprietary signal-processing biomarkers to optimize clinical treatments. The company develops NOCISCAN, which uses MRS capabilities to non-invasively analyze the chemical makeup of intervertebral discs in the spine. It also provides NOCISCAN MRS Exam Protocol, a custom software protocol for using commercial...
IPO Date Jul 17, 2026
Employees 10
Stock Exchange NasdaqCM
Ticker Symbol ACONW
Website https://www.aclarion.com
Financial Performance
In 2025, Aclarion's revenue was 75.73K, an increase of 65.62% compared to the previous year's 45.72K. Earnings were -7.23M, an increase of 3.44%.
Financial Statements
